| 000 | 01787cam a2200337 a 4500 | ||
|---|---|---|---|
| 003 | EG-GiCUC | ||
| 005 | 20250223030735.0 | ||
| 008 | 130109s2012 ua h f m 000 0 eng d | ||
| 040 |
_aEG-GiCUC _beng _cEG-GiCUC |
||
| 041 | 0 | _aeng | |
| 049 | _aDeposite | ||
| 097 | _aM.Sc | ||
| 099 | _aCai01.11.06.M.Sc.2012.Ab.N | ||
| 100 | 0 | _aAbdelsattar Elsaid Ali Seif | |
| 245 | 1 | 0 |
_aNemulized magnesium sulphate versus nebulized salbutamol in acute bronchial asthma / _cAbdelsattar Elsaid Ali ; Supervised Esmat Ali Abdelnabi , Mohammed Mostafa Kamel |
| 246 | 1 | 5 | _aمقارنة بين سلفات الماغنسيوم و السالبيوتامول عن طريق الأستنشاق في علاج أزمات الربو الشعبي |
| 260 |
_aCairo : _bAbdelsattar Elsaid Ali Seif , _c2012 |
||
| 300 |
_a121 P. : _bfacsimiles ; _c25cm |
||
| 502 | _aThesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Chest Diseases and Tuberculosis | ||
| 520 | _aAsthma exacerbations can be frequent and range in severity from relatively mild to status asthmaticus. Currently inhaled Ý2 agonists are the main stay of therapy for asthmatic patients. Patients resistant to beta agonists are prescribed corticosteroid therapy but this often requires hours to demonstrate significant benefit. Methylxanthines like theophylline have a low therapeutic index and show frequent side effects, making it increasingly unpopular | ||
| 530 | _aIssued also as CD | ||
| 653 | 4 | _aAcute severe asthma | |
| 653 | 4 | _aChlorofluorocarbon | |
| 653 | 4 | _aInterleukin | |
| 700 | 0 |
_aEsmat Ali Abdelnabi , _eSupervisor |
|
| 700 | 0 |
_aMohammed Mostafa Kamel , _eSupervisor |
|
| 856 | _uhttp://172.23.153.220/th.pdf | ||
| 905 |
_aNazla _eRevisor |
||
| 905 |
_aSamia _eCataloger |
||
| 942 |
_2ddc _cTH |
||
| 999 |
_c40958 _d40958 |
||